The $5.1M of total grant support we've given to funding research is made possible by the generosity of our sponsors and donors. Real people making an impact on saving children's eyesight.
Grant History
Grant Amount
$3M
2024
$2.1M
2025
Latest Posts
- All
- About BBS
- Behind The Scenes
- Community Stories
- Grant Announcements
- Gratitude Gallery
- is RAB legit?
- Research
September 19, 2025
New Hope for Retinitis Pigmentosa: FDA Grants Fast Track Designation for ADX-2191
FDA Fast Tracks Potential RP Treatment
Aldeyra’s ADX-2191 has received Fast Track Designation from the FDA for retinitis pigmentosa. With no approved treatments currently available for most RP patients, this milestone could help speed the development of a promising new therapy.
September 15, 2025
Nanoscope Therapeutics Advances One-Time Gene Therapy for Retinitis Pigmentosa and Stargardt Disease
Hope for RP and Stargardt Disease
Nanoscope Therapeutics is advancing a one-time gene therapy designed to restore vision for patients with retinitis pigmentosa and Stargardt disease. If successful, this treatment could transform care for two conditions that currently have no approved therapies.
September 15, 2025
Stem Cell–Derived Retinal Sheets Enter Clinical Trial for Retinitis Pigmentosa
Stem Cell–Derived Retinal Sheets Trial for RP
A new clinical trial is testing DSP-3077, a one-time stem cell–derived retinal sheet implant, as a potential treatment for retinitis pigmentosa. This regenerative therapy could offer hope for patients regardless of genetic subtype. Learn how this groundbreaking study may shape the future of RP treatment.
Grant Announcements
September 04, 2025
Celebrating a $1M Milestone for Sight-Saving Science
Read More
September 01, 2025
Why We Run Multiple Fundraisers
Some wonder why we host several fundraisers each year. The answer is urgency: children with Bardet-Biedl Syndrome are losing vision every day. Running multiple campaigns helps us raise funds quickly, reach more people, and keep hope alive for sight-saving research.